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Abstract
CLC chloride/proton exchangers may support acidification of
endolysosomes and raise their luminal Cl concentration. Disrup-
tion of endosomal ClC-3 causes severe neurodegeneration. To
assess the importance of ClC-3 Cl/H+ exchange, we now generate
Clcn3unc/unc mice in which ClC-3 is converted into a Cl channel.
Unlike Clcn3/ mice, Clcn3unc/unc mice appear normal owing to
compensation by ClC-4 with which ClC-3 forms heteromers. ClC-4
protein levels are strongly reduced in Clcn3/, but not in
Clcn3unc/unc mice because ClC-3unc binds and stabilizes ClC-4 like
wild-type ClC-3. Although mice lacking ClC-4 appear healthy, its
absence in Clcn3unc/unc/Clcn4/ mice entails even stronger
neurodegeneration than observed in Clcn3/ mice. A fraction of
ClC-3 is found on synaptic vesicles, but miniature postsynaptic
currents and synaptic vesicle acidification are not affected in
Clcn3unc/unc or Clcn3/ mice before neurodegeneration sets in.
Both, Cl/H+-exchange activity and the stabilizing effect on ClC-4,
are central to the biological function of ClC-3.
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Introduction
Ion homeostasis of intracellular organelles like endosomes, lyso-
somes, and synaptic vesicles (SVs) is important for luminal enzyme
activity, ligand–receptor interactions, transmembrane voltage,
transport of neurotransmitters, and other substrates across their
limiting membranes, as well as vesicle budding, fusion, and traf-
ficking. To date, most studies concentrated on luminal pH that drops
along the endosomal/lysosomal pathway. This acidification is driven
by the proton pump activity of V-type ATPases that need a neutraliz-
ing counter current. This current is believed to be carried mainly by
chloride ions, although acidification of lysosomes prominently
depends on cation channels (Steinberg et al, 2010; Weinert et al,
2010). The Cl-dependent shunt was previously thought to be medi-
ated by CLC Cl channels (Gu¨nther et al, 1998; Piwon et al, 2000;
Kornak et al, 2001), but the vesicular ClC-3 to ClC-7 proteins, in
contrast to the plasma membrane Cl channels (ClC-1, ClC-2, and
ClC-K), are rather 2Cl/H+-exchangers (Picollo & Pusch, 2005;
Scheel et al, 2005; Neagoe et al, 2010; Weinert et al, 2010; Leisle
et al, 2011; Rohrbough et al, 2018). Both, CLC channels and
exchangers function as dimers with two independent ion permeation
pathways that are entirely contained within each CLC monomer
(Ludewig et al, 1996; Middleton et al, 1996; Weinreich & Jentsch,
2001; Dutzler et al, 2002; Zdebik et al, 2008; Jentsch & Pusch, 2018).
The physiological importance of vesicular CLCs is highlighted by
mouse models and patients carrying CLCN mutations. Their patholo-
gies range from impaired renal endocytosis and kidney stones (ClC-
5) (Lloyd et al, 1996; Piwon et al, 2000; Wang et al, 2000) to severe
neurodegeneration (ClC-3) (Stobrawa et al, 2001), intellectual
disability and epilepsy (ClC-4) (Veeramah et al, 2013; Hu et al,
2016; Palmer et al, 2018), to lysosomal storage disease (ClC-6) (Poe¨t
et al, 2006) or osteopetrosis associated with lysosomal storage and
neurodegeneration (ClC-7) (Kornak et al, 2001; Kasper et al, 2005).
A gain-of-function mutation in CLCN7 causes lysosomal storage
disease and hypopigmentation without osteopetrosis (Nicoli et al,
2019).
Not only Cl channels, but also electrogenic 2Cl/H+-exchan-
gers are able to shunt proton pump currents. Indeed, the 2Cl/H+-
exchanger ClC-5 may support the acidification of renal endosomes
(Gu¨nther et al, 2003; Hara-Chikuma et al, 2005a; Novarino et al,
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2010) and ClC-7 is required to acidify the resorption lacuna of osteo-
clast (Kornak et al, 2001). However, more recent experiments
demonstrate that the exchange activity, rather than the provision of
an electrical shunt, is crucial for most biological roles of ClC-5 and
ClC-7 (Novarino et al, 2010; Weinert et al, 2010). Clcn5unc and
Clcn7unc/unc knock-in mice which carry uncoupling point mutations
in the “gating glutamate”, a pore residue critically involved in 2Cl/
H+-exchange (Accardi & Miller, 2004), revealed that the conversion
of 2Cl/H+-exchange into a pure Cl conductance causes similar
pathologies as the disruption of Clcn5 and Clcn7, respectively
(Novarino et al, 2010; Weinert et al, 2010). Comparable uncoupling
mutations in CLCN5 were subsequently identified in patients with
Dent’s disease (Sekine et al, 2014; Bignon et al, 2018). These obser-
vations suggest an important role for proton-driven endosomal–
lysosomal Cl accumulation. Indeed, lysosomal Cl concentration,
but not luminal pH, was reduced in both Clcn7/ and Clcn7unc/unc
mice (Weinert et al, 2010).
The transport properties of ClC-3 had been highly controversial
(for review, see (Jentsch, 2008; Jentsch & Pusch, 2018)), but it is
now established that ClC-3 is a vesicular 2Cl/H+-exchanger (Mat-
suda et al, 2008; Guzman et al, 2013; Jentsch & Pusch, 2018; Rohr-
bough et al, 2018) like the close homologs ClC-4 and ClC-5 (Picollo
& Pusch, 2005; Scheel et al, 2005) and the other vesicular CLCs. In
addition to its presence on endosomes, ClC-3 may also be found on
SVs (Stobrawa et al, 2001; Salazar et al, 2004; Seong et al, 2005;
Grønborg et al, 2010) and synaptic-like microvesicles (SLMVs) of
neuroendocrine cells (Salazar et al, 2004; Maritzen et al, 2008).
However, more recent work questioned a significant presence of
ClC-3 on SVs (Schenck et al, 2009). Furthermore, these authors
suggested that the reduced acidification of SVs from Clcn3/ mice
(Stobrawa et al, 2001) rather results from a secondary decrease in
the vesicular glutamate transporter VGLUT1 which may also
conduct chloride (Schenck et al, 2009).
We now asked whether the biological role of ClC-3 depends on
its Cl/H+ exchange activity or on its electrical conductance and
whether ClC-3 is important for SV function. In stark contrast to the
severe neurodegeneration of Clcn3/ mice (Stobrawa et al, 2001;
Dickerson et al, 2002; Yoshikawa et al, 2002), newly generated
Clcn3unc/unc mice carrying an uncoupling mutation in ClC-3 lacked
detectable phenotypes. This could be explained by a compensation
by ClC-4 with which ClC-3 forms heteromers in vivo. Disruption of
ClC-3 leads to increased ER retention and degradation of ClC-4,
suggesting that a reduction of ClC-4 levels contributes to the severe
neurodegeneration of Clcn3/ mice. We also demonstrated that
ClC-3 is expressed on a fraction of SVs and that miniature postsy-
naptic currents and SV acidification were not affected in young
Clcn3/ mice before the onset of neurodegeneration. Proton-driven
Cl transport by ClC-3, if not compensated by ClC-4, is crucial for
the integrity of the CNS. ClC-3 overwhelmingly localizes to endo-
somes and apparently has no significant role in SVs.
Results
Clcn3unc/unc mice do not display neurodegeneration
To elucidate whether the electrical conductance or the Cl/H+-
exchange activity of ClC-3 is crucial for its biological role, we
generated Clcn3unc/unc knock-in mice carrying the E224A mutation
in the “gating glutamate” (Appendix Fig S1A–D). When studied in a
ClC-3 construct that partially localizes to the plasma membrane
(Zhao et al, 2007) (Fig EV1A), this mutation linearized the normally
strongly outwardly rectifying ClC-3 currents (Fig EV1B and C). As
previously observed with the bacterial ecClC exchanger (Accardi &
Miller, 2004) and mammalian ClC-4 through ClC-7 (Picollo & Pusch,
2005; Scheel et al, 2005; Neagoe et al, 2010; Leisle et al, 2011), this
mutation also uncouples Cl currents from H+ countertransport
(Rohrbough et al, 2018). “Uncoupled” CLC exchangers mediate
channel-like Cl conductances without appreciable transport of H+.
Clcn3unc/unc mice were viable and expressed the mutant ClC-3unc
protein at wild-type (WT) levels (Appendix Fig S1E). These mice
were born at Mendelian ratios, were fertile, and had no obvious
phenotype. Even at 20 months of age, they neither displayed the
severe degeneration of the CNS nor of the retina (Fig 1A and B) that
is observed in Clcn3/ mice (Stobrawa et al, 2001; Dickerson et al,
2002; Yoshikawa et al, 2002). This contrasts with findings for
Clcn5unc and Clcn7unc/unc mice (Novarino et al, 2010; Weinert et al,
2010) which phenotypically largely resemble the respective null
mice (Piwon et al, 2000; Kornak et al, 2001). These observations
raised the possibility that another vesicular CLC protein might
compensate for the loss of ClC-3 2Cl/H+-exchange in Clcn3unc/unc,
but not in Clcn3/ mice.
ClC-4 levels are reduced in Clcn3/, but not in Clcn3unc/unc mice
We therefore examined the expression levels of ClC-4 and ClC-5, the
closest homologs of ClC-3 (~ 76% identity), in tissues of Clcn3unc/unc
and Clcn3/ mice. Although ClC-4 mRNA levels are not changed in
the brain of Clcn3/ mice (Stobrawa et al, 2001), ClC-4 protein
levels were strongly and more moderately decreased in brain and
kidney of Clcn3/ mice, respectively (Fig 1C–E). Depending on the
tissue and experimental conditions, the ClC-4 band often appeared
as doublet in Clcn3/mice (Fig EV2B). Western blot quantifications
of the upper band, which likely reflects the mature glycosylated form
of ClC-4 (see below), revealed that it was reduced down to 30 and
60% in brain and kidney of Clcn3/ mice, respectively (Fig 1E). In
heterozygous Clcn3+/ mice, ClC-4 protein amounts were reduced
down to ~ 65% in brain and ~ 80% in kidney (Fig 1C and D).
Expression of ClC-5, which is found in kidney but is almost absent
from brain, appeared unchanged upon Clcn3 disruption (Fig 1C).
ClC-4 protein levels were markedly reduced in all other Clcn3/
tissues examined, including liver, pancreas, adrenal gland, spleen,
lung, skeletal muscle, and heart (Fig EV2B). Treatment with PNGase
F, which removes all N-linked glycans, showed that differences in
size of ClC-4 were due to differential glycosylation (Fig EV2C). In
contrast to the larger ClC-4 species, the lower band, which was much
more prominent in most Clcn3/ tissues, was sensitive to digestion
with Endo H that cleaves oligosaccharides of core-glycosylated ER-
resident membrane proteins (Fig EV2D). This indicated that in
Clcn3/ mice, a sizeable portion of ClC-4 does not leave the ER,
where it is subject to degradation. Importantly, no reduction of ClC-4
protein levels was observed in brain or kidney of Clcn3unc/unc mice
(Figs 1C and EV2A) which express an “uncoupled”, but otherwise
intact ClC-3 protein. Importantly, whereas ClC-4 levels depended on
ClC-3, ClC-3 levels were unchanged in both brain and kidney of
Clcn4/mice (Fig EV2A).
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Figure 1. Hippocampal morphology and expression of intracellular CLC proteins of Clcn3 mouse models.
A Nissl-stained sagittal brain sections reveal no change in hippocampal morphology between Clcn3unc/unc and Clcn3+/+ mice at P45 or after 20 months. In contrast, the
hippocampus was absent (indicated by asterisk) in 3-month-old Clcn3/ mice (scale bar: 200 lm).
B Nissl-stained paraffin sections show intact retinal layers in 20-month-old Clcn3unc/unc mice. Neurodegeneration in Clcn3/ mice, however, results in a loss of retinal
structure already at 11 weeks of age (scale bar: 100 lm). GCL, ganglion cell layer; INL, inner nuclear layer; IPL, inner plexiform layer; IS, photoreceptor inner
segments; ONL, outer nuclear layer; OPL, outer plexiform layer; OS, photoreceptor outer segments; RPE, retinal pigment epithelium.
C Immunoblots for ClC-3, ClC-4, and CIC-5 of membrane fractions of WT (+/+), Clcn3unc/unc (unc/unc), Clcn3unc/+ (unc/+), and Clcn3/ (/) mice. b-Actin, loading
control.
D Representative Western blot for ClC-4 of membrane fractions from brain and kidney of WT (+/+), Clcn3+/ (+/), and Clcn3/ (/) mice. b-Actin, loading control.
E Quantification of ClC-4 immunoblots including those shown in (C, D) (normalized to actin). Mean values  SEM. Average from ≥ 5 animals per genotype and at ≥ 2
immunoblots per animal. ***P < 0.0005, **P < 0.005, *P < 0.05 (two-tailed unpaired t-test).
Source data are available online for this figure.
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ClC-3 and ClC-3unc heteromerize with ClC-4
CLC proteins function as dimers (Ludewig et al, 1996; Middleton
et al, 1996; Dutzler et al, 2002). With the exception of ClC-6 and
ClC-7, heterodimers have been observed upon heterologous co-
expression of members of the same homology branch (Lorenz et al,
1996; Weinreich & Jentsch, 2001; Mohammad-Panah et al, 2003;
Suzuki et al, 2006; Guzman et al, 2017). We therefore suspected
that ClC-3 stabilizes ClC-4 by forming heterodimers in vivo. Indeed,
ClC-3 antibodies co-immunoprecipitated ClC-4 from both WT and
Clcn3unc/unc brain and vice versa (Fig 2A). These results were
corroborated by Fo¨rster resonance energy transfer (FRET) measure-
ments with fluorescently tagged ClC-3 and ClC-4 in transfected COS-
7 cells (Fig 2B). Agreeing with previous results obtained with over-
expressing HEK cells (Okkenhaug et al, 2006; Guzman et al, 2017),
ClC-4 showed typical ER-like reticular staining when expressed in
COS-7 cells (Fig 2C). In contrast, ClC-3 localized to vesicular struc-
tures, which were partially positive for the late endosomal/lysoso-
mal marker Lamp-1 (Fig 2C). When both CLCs were co-transfected,
ClC-4 co-localized with ClC-3 in vesicles (Fig 2D) (Guzman et al,
2017). A similar change in ClC-4 localization was observed upon co-
expression with the ClC-3unc mutant (Fig 2D), as expected from our
observation that the mutant ClC-3 protein retains its physical inter-
action with ClC-4 (Fig 2A). Hence, both WT ClC-3 and ClC-3unc
associate with ClC-4 and thereby promote the transport of ClC-4
from the ER to endosomal–lysosomal compartments and protects it
from degradation.
Severe neurodegeneration in Clcn3unc/unc/Clcn4/ mice
The above experiments suggested that ClC-4 may compensate for a
loss of ClC-3 function in Clcn3unc/unc, but not in Clcn3/ mice in
which brain ClC-4 levels are decreased to ~ 30% of WT (Fig 1E). To
completely eliminate this potential compensation, we crossed
Clcn3unc/unc mice with Clcn4/ mice. Although Clcn4/ mice
appear to be normal (Rickheit et al, 2010), we reassessed potential
effects of Clcn4 disruption because mutations in CLCN4 were
recently associated with X-linked intellectual disability and epileptic
encephalopathy (Veeramah et al, 2013; Hu et al, 2016; Palmer et al,
A
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Figure 2. Formation of ClC-3/ClC-4 heteromers.
A Co-immunoprecipitation reveals a ClC-3–ClC-4 complex. Ten percent of
solubilized brain membranes of WT and Clcn3unc/unc mice were directly
loaded on the gel (input, or first immunoprecipitated (IP) with antibodies
against ClC-3 or ClC-4). Western blots were probed for ClC-3 and ClC-4.
Equivalent amounts of lysates and precipitates were loaded. * unspecific
band/contamination.
B FRET experiments show homo- and heteromerization of ClC-3 and ClC-4
constructs [fused to yellow fluorescent protein (YFP) and cyan fluorescent
protein (CFP)] overexpressed in COS-7 cells. Co-expressed constructs are
indicated. Graph represents energy transfer efficiencies from acceptor
photobleaching, depicted as bleach corrected values (subtraction of ClC-
4CFP alone). Mean values  SEM. N = 20 (ClC-3YFP/ClC-4CFP); 33 (ClC-
3YFP/ClC-3CFP); 26 (ClC-4YFP/ClC-4CFP); 42 (ClC-3YFP/Lamp-1CFP) cells.
***P < 0.0005 (two-tailed unpaired t-test).
C Immunolabeling shows subcellular localization of hClC-4 (top, green in
merge), hClC-3 (middle, green in merge), and hClC-3unc (bottom, green in
merge) of transiently transfected COS-7 cells, in comparison with either PDI
or Lamp-1 (both red) as marker for the ER and late endosomes/lysosomes,
respectively.
D Co-localization of hClC-3 and hClC-4 in cytoplasmic vesicles of COS-7 cells
transfected with hClC-4 cDNA [hemagglutinin (HA) tagged] together with
either hClC-3 or hClC-3unc. Immunostaining used antibodies against ClC-3
and HA tag (green and red in merge, respectively).
Data information: DNA stained with DAPI in (C) and (D), [scale bar in (C) and
(D): 20 lm].
Source data are available online for this figure.
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2018). However, Clcn4/ mice neither displayed discernible
anatomical changes in the brain (Appendix Fig S2), nor obvious
behavioral abnormalities.
Clcn3unc/unc/Clcn4/ mice were born at Mendelian ratio. Similar
to Clcn3/ mice (Stobrawa et al, 2001; Dickerson et al, 2002; Yoshi-
kawa et al, 2002), they were growth-retarded. Most died within
5 weeks after birth and only ~ 20% became older than 10 weeks
(Fig 3A). Brains from Clcn3unc/unc/Clcn4/ mice displayed severe
neurodegeneration (Fig 3B). Like in Clcn3/ mice (Stobrawa et al,
2001), degeneration became first apparent in the hippocampus, but
progressed much faster. Whereas the hippocampus began to show
mild degeneration at P21 and almost totally disappeared at 10 weeks
of age in Clcn3/ mice (Stobrawa et al, 2001), Clcn3unc/unc/Clcn4/
mice showed severe hippocampal degeneration at P21 and mice had
lost their hippocampi already 4 weeks after birth (Fig 3B). Again simi-
lar to Clcn3/ mice, neurodegeneration in Clcn3unc/unc/Clcn4/ mice
was accompanied by an activation of astrocytes as indicated by GFAP
staining. Clcn3unc/unc/Clcn4/ mice showed severe retinal degenera-
tion (Fig 3C), similar to Clcn3/ mice (Stobrawa et al, 2001).
The more severe phenotype of Clcn3unc/unc/Clcn4/ compared
to Clcn3/ mice suggested that the severity of neurodegeneration
depends on the expression levels of ClC-4. Clcn3unc/unc/Clcn4+/
mice, in which ClC-4 protein levels are reduced to 75% of normal,
did not show neurodegeneration even at 12 weeks of age
(Appendix Fig S3A). Likewise, on a Clcn4/ background, heterozy-
gous Clcn3unc alleles did not cause pathologies (Appendix Fig S3B).
In contrast, only very few Clcn3//Clcn4/ mice were born and
then died shortly after birth (Fig 3A). Hence, ClC-3 and ClC-4 have
partially overlapping functions. The occurrence of neurodegenera-
tion in Clcn3/, but not Clcn4/ mice might be largely explained
by the fact that ClC-4 levels are strongly decreased in Clcn3/ mice,
whereas ClC-3 abundance does not depend on ClC-4. As revealed
only in the absence of ClC-4, the pure Cl conductance of ClC-3unc
cannot functionally replace the 2Cl/H+-exchange of WT ClC-3.
However, this conductance may substitute for some aspect of ClC-3
function as revealed by the milder phenotype of Clcn3unc/unc/
Clcn4/ compared to Clcn3//Clcn4/ mice. However, we
cannot exclude that the more severe phenotype of the double
knock-out is in part owed to the lack of the ClC-3 protein that might
bind to unknown interaction partners.
Subcellular localization of ClC-3 and ClC-4 in brain
Because available ClC-3 antibodies are of limited use for immuno-
histochemistry (IHC) of native tissue, we generated knock-in mice
in which we epitope-tagged ClC-3 (Appendix Fig S4A and B). We
A
B
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Figure 3. Life span and neurodegeneration of Clcn3/Clcn4mousemodels.
A Clcn3unc/unc/Clcn4/ and Clcn3/ mice died within 3–4 weeks after birth.
Approximately 20% of the animals survived in either line (Clcn3unc/unc/
Clcn4/, n = 136, and Clcn3/, n = 187). All Clcn3//Clcn4/ mice
(n = 4) died within 1–2 weeks after birth.
B Nissl-stained paraffin sections show progressive neuronal cell loss (arrows)
that begins in hippocampal CA1 region of P14 Clcn3unc/unc/Clcn4/ mice
and results in a complete loss of the hippocampus at P28.
Neurodegeneration progresses slower in Clcn3/ mice (Stobrawa et al,
2001) (scale bar: 200 lm).
C Semi-thin sections of P28 retinae revealed degeneration of photoreceptor
cells in the outer nuclear layer and outer and inner segment of Clcn3unc/unc/
Clcn4/, but not of Clcn3unc/unc or Clcn4/ mice (scale bar: 50 lm). GCL,
ganglion cell layer; INL, inner nuclear layer; IPL, inner plexiform layer; IS,
photoreceptor inner segments; ONL, outer nuclear layer; OPL, outer
plexiform layer; OS, photoreceptor outer segments; RPE, retinal pigment
epithelium.
Source data are available online for this figure.
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opted for a Venus tag (ven), a fast-maturing and brightly fluores-
cent variant of the green fluorescent protein (GFP) (Nagai et al,
2002), which we fused to the N-terminus of ClC-3. Homozygous
Clcn3ven/ven mice were born at Mendelian ratio, had a normal life
expectancy and did not show neurodegeneration even at
10 weeks of age (Appendix Fig S4C). Clcn3ven/ven/Clcn4/ mice
did not display hippocampal degeneration either (Appendix Fig
S4C), suggesting that the VenusClC-3 fusion protein functions
normally. VenusClC-3 protein levels were undistinguishable from
ClC-3 levels in WT mice (Appendix Fig S4D). Since low fluores-
cence intensities precluded direct imaging of VenusClC-3 fluores-
cence in tissue sections, we used anti-GFP antibodies in IHC. In
brain, VenusClC-3 was most prominently expressed in the hilus
and stratum lucidum of the hippocampus and in the cerebellum
(Appendix Fig S5A and B). IHC for ClC-4 revealed a similar distri-
bution (Appendix Fig S5C). The absence of signals for VenusClC-3
and ClC-4 in tissue from WT and Clcn4/ mice, respectively,
validated the specificity of our labeling (Appendix Figs S5B and
C, and Fig 4A).
Compatible with the formation of ClC-3/4 heteromers in vivo,
VenusClC-3 and ClC-4 co-localized in punctate pattern in cell bodies
and neurites of hippocampal pyramidal neurons (Fig 4B). Both in
brain sections and in cultured hippocampal neurons of Clcn3ven/ven
mice, ClC-3 localized to compartments that were positive for the
endosomal marker EEA1 or for Lamp-1, a marker of late endosomes
and lysosomes (Fig 4C and D). Roughly 30, 20, and 10% of
VenusClC-3-positive structures in somata of cultured hippocampal
neurons were co-labeled for transferrin receptor (TfR), EEA1, and
Lamp-1, respectively (Appendix Fig S6). We also found VenusClC-3
in astrocytes and oligodendrocytes (Fig EV3A) where it co-localized
with rab4, EEA1, and TfR, but not significantly with Lamp-1
(Fig EV3B). Neither VGLUT1 nor synaptophysin, both markers for
SVs, showed significant co-localization with ClC-3 (Fig 4C and D).
However, ClC-3 was described to also localize to SVs (Stobrawa
et al, 2001; Salazar et al, 2004; Seong et al, 2005; Grønborg et al,
2010) and SLMVs (Salazar et al, 2004; Maritzen et al, 2008) and to
affect synaptic physiology (Wang et al, 2006; Riazanski et al, 2011;
Guzman et al, 2014). Based on comparisons of ClC-3 with VGLUT1
levels in quantitative Western blots, however, Schenck et al (2009)
reported that ClC-3 was present on only every 2,000th SV. We there-
fore re-examined this important issue. Immunoblots detected ClC-3
and ClC-4 in the LP2 fraction of brain membranes, which is enriched
for SVs as indicated by the accumulation of synaptophysin
(Fig EV4A and B) and the virtual absence of postsynaptic PSD95
(Fig EV4A). Using our KO-controlled ClC-3 antibody (Stobrawa
et al, 2001) and a VGLUT1 construct that was epitope-tagged at the
N-terminus for antibody calibration, quantitative Western blot
analysis suggested that the copy number ratio of ClC-3/VGLUT1 in
the LP2 fraction is ~ 1/250 (Fig EV4C–E). This value is much higher
than the ClC-3/VGLUT1 ratio of ~ 1/5,000 in the SV fraction
reported by Schenck et al who have used a similar approach but
had tagged VGLUT1 at the C-terminus. Taking into account the typi-
cal SV content of the LP2 fraction (~ 50%) (Huttner et al, 1983) and
the number of VGLUT1 on SVs (~ 10) (Takamori et al, 2006), our
results yielded the rough estimate of one ClC-3 protein on every 25th
SV (Fig EV4C–E). The expression of ClC-3 on endosomes, the pres-
ence of endosomal structures in synaptic boutons (Watanabe et al,
2014; Milosevic, 2018), and the presence of the endosomal marker
rab4 and lysosomal cathepsin D in LP2 fractions (Fig EV4B) suggest
that the abundance of ClC-3 on SVs might even be lower.
We further examined the presence of ClC-3 on SVs by single-
vesicle imaging (Farsi et al, 2016). Venus-tagged SVs purified from
brain of Clcn3ven/ven mice (Fig 4E) were immobilized on coated
glass cover slips at low density and imaged using total-internal
reflection fluorescence (TIRF) microscopy (Fig 4F). The well-sepa-
rated vesicles allowed to correlate the expression of ClC-3 with
those of the SV marker proteins synaptophysin or VGLUT1 by
immunofluorescence (IF). Roughly 10% of vesicles stained for
either VGLUT1 or synaptophysin showed Venus-ClC-3 fluorescence
(Fig 4G). This value may underestimate the proportion of SVs
containing ClC-3 since the procedures needed to detect VGLUT1 and
synaptophysin by IF affected Venus fluorescence. Sixty and
eighty percent of Venus-ClC-3 containing vesicles were labeled for
VGLUT1 or synaptophysin, respectively (Fig 4H and I), suggesting
that the remainder might represent GABAergic SVs or endosome-
like vesicles.
Collectively, these data show that ClC-3 is present on a consider-
ably larger fraction of SVs than reported by Schenck et al (2009).
Although both types of experiments (Figs EV4 and 4F–H) gave
quantitatively different results, they suggest that maybe 5–15% of
SVs contain ClC-3. As indicated by IHC of brain sections, however,
the bulk of ClC-3 is rather found on endosomes.
Acidification of synaptic vesicles and neuronal endosomes
ClC-3 was reported to support the acidification of endosomes
(Yoshikawa et al, 2002; Hara-Chikuma et al, 2005b; Weylandt et al,
2007) and SVs (Stobrawa et al, 2001; Riazanski et al, 2011) by
providing an electric shunt for proton pumping. However, more
recent work (Schenck et al, 2009) suggested that impaired SV acidi-
fication in Clcn3/ mice may rather be due to the observed reduc-
tion in the levels of VGLUT1 (Stobrawa et al, 2001), which, in
addition to its role as glutamate transporter, may also conduct Cl
(Schenck et al, 2009; Preobraschenski et al, 2014; Eriksen et al,
2016; Martineau et al, 2017).
Since the impairment of SV acidification in Clcn3/ mice may
be age-dependent (Schenck et al, 2009), expression levels of ClC-3,
ClC-4, and key synaptic proteins in the brain of WT and Clcn3/
mice were examined as function of age (Fig 5A). In WT mice, ClC-3
and ClC-4 expression remained constant over the time span investi-
gated (2–12 weeks), as did the changes in ClC-4 observed in
Clcn3/ mice (Figs 1C–E and 5A). Protein levels of the vesicular
GABA transporter VGAT, the a1 subunit of the GABAA receptor, and
the GluR4 subunit of the glutamate receptor did not change with age
and were not affected by Clcn3 disruption. By contrast, VGLUT1
expression markedly increased between 2 and 6 weeks of age,
whereas VGLUT2 levels declined over the entire time span. In line
with our previous observations (Stobrawa et al, 2001), VGLUT1
levels were markedly reduced compared to WT in 6- and 12-week-
old Clcn3/ mice (Fig 5A) which already display overt neurodegen-
eration (Stobrawa et al, 2001).
ATP-driven luminal acidification of SV-enriched LP2 fractions
was assessed by acridine orange quenching (Fig 5B). Correlating
with the decrease of VGLUT1, Clcn3 disruption decreased ATP-
driven acidification of LP2 vesicles at 6 and 12, but not at 2 weeks
of age (Fig 5C). LP2 fractions from either Clcn3unc/unc or Clcn4/
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Figure 4. Subcellular localization of VenusClC-3 and ClC-4 in neurons.
A GFP antibodies immunolabel VenusClC-3 (green) in the somata of CA1 pyramidal neurons of Clcn3ven/ven, but not Clcn3+/+ brain sections. sp, stratum pyramidale
(scale bar: 20 lm).
B Co-immunolabeling of VenusClC-3 (green) with ClC-4 (red) in the CA3 region of Clcn3ven/ven mice (scale bar: 20 lm). sl, stratum lucidum; sp, stratum pyramidale.
C Co-immunostaining of VenusClC-3 (green) with EEA1 (red, left panel), Lamp-1 (red, middle panel), or synaptophysin (red, right panel) in either CA1 or CA3 region of
Clcn3ven/ven mice. Arrows indicate structures of overlap (scale bar: 5 lm).
D GFP antibody immunolabels VenusClC-3 (green) in neurites of cultured neurons. EEA1 and VGLUT1 are co-stained (both in red; left and right panel, respectively). The
dendritic marker MAP2 is stained in blue (right panel; scale bars: 10 lm). DNA stained with DAPI.
E Immunoblot analysis of fractions collected during preparation of SVs from brain of Clcn3ven/ven mice. VenusClC-3 (detected with GFP antibody) co-purified with SV
marker protein synaptophysin.
F Fluorescence of immobilized Venus-tagged SVs imaged with TIRF microscopy. Scale bar, 2 lm.
G, H Co-localization between the Venus-tagged vesicles with antibodies against VGLUT1 and synaptophysin was analyzed. (G) 11.4  0.6 (SD) of VGLUT1-labeled SVs
and 8.2  2 (SD) of synaptophysin-labeled SVs showed Venus fluorescence (n = 6). (H) 65  5.4 (SD) and 79.4  3.8 (SD) of Venus-tagged SVs showed co-
localization with VGLUT1 and synaptophysin, respectively (n = 6).
I Co-immunolabeling of VenusClC-3 (green) with synaptophysin (red) of immobilized SVs imaged with TIRF microscopy. Vesicle in quadrant delimited by dashed line
is shown in higher magnification in merge. Scale bar, 2 lm.
Source data are available online for this figure.
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Figure 5. ATP-induced acidification of synaptic vesicle-enriched LP2 fraction derived from different Clcn3 and Clcn4 mouse models.
A Immunoblots for ClC-3, ClC-4, VGLUT1, VGLUT2, VGAT, GluR4, and GABAA-R-a1 of whole lysates from brain of Clcn3
+/+ and Clcn3/ mice at 2, 6, and 12 weeks of age.
B Acidification of synaptic vesicle LP2 fractions from Clcn3unc/unc and Clcn3+/+ mice at 1 year of age (upper panel, n = 2 animals each and ≥ 3 measurements per
animal), 10-week-old Clcn4/ and WT mice (middle panel, n = 3 animals each and ≥ 3 measurements per animal), and 4- to 6-week-old Clcn3unc/unc/Clcn4/ and
control mice (lower panel, six animals each with ≥ 2 measurements per animal). A decrease in fluorescence reflects acidification. The protonophore FCCP dissipated
the pH gradient. Mean values  SEM.
C Quantification of ATP-induced acidification of LP2 fractions derived from 2, 6, and 10- to 12-week-old Clcn3/ compared to wild-type mice. Acidification measured
by acridine orange fluorescence in the presence of 60 mM KCl. At least two animals in at least two independent experiments were pooled. Each measurement was
performed at least three times. Mean  SEM is shown.*P < 0.05, ***P < 0.0005 (two-tailed unpaired t-test).
D Immunoblot revealed strong reduction of VGLUT1 levels in the homogenate (H) and LP2 fraction of Clcn3unc/unc/Clcn4/ mice.
E Endosomal pH of Clcn3+/+ and Clcn3/ primary hippocampal neurons determined with a pH-sensitive transferrin conjugate. N = 5 independent cell lines with at
least two live cell dishes per cell line with about 10 images each and ≥ 10 Tfn-positive compartments per image and genotype were analyzed. Mean  SEM is
shown.
Source data are available online for this figure.
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mice, which do not show neurodegeneration, exhibited normal
ATP-driven acidification. However, acidification of vesicles obtained
from Clcn3unc/unc/Clcn4/ mice with fast progressing neurodegen-
eration and strong reduction of VGLUT1 levels (Fig 5D) was mark-
edly reduced even at 4–6 weeks of age when compared to control
littermates (Fig 5B).
We also determined luminal pH of TfR-positive endosomal
compartments in cultured neurons by ratiometric imaging. pH-sensi-
tive and pH-insensitive transferrin-coupled conjugates Tfn-FITC and
Tfn-546, respectively, were chased into recycling endosomes after
endocytosis. Immunolabeling showed that roughly 80% of TfR-expres-
sing compartments contained VenusClC-3 (Appendix Fig S6). There was
no significant difference in average pH between WT [5.36  0.07
(SEM)] and Clcn3/ endosomes (pH 5.48  0.11; Fig 5E), suggesting
that ClC-3 does not provide the main shunt conductance for the acidifi-
cation of TfR-positive neuronal compartments.
Effect of ClC-3 on synaptic function and structure
The failure of Clcn3 disruption to impair SV acidification before the
onset of neurodegeneration questioned a role of ClC-3 in loading SVs
with neurotransmitters. Indeed, in our previous work (Stobrawa
et al, 2001), Clcn3 disruption did not affect the amplitude or
frequency of miniature inhibitory postsynaptic currents (mIPSCs)
which are elicited by spontaneous exocytosis of GABA-containing
SVs. We had only detected marginal effects on miniature excitatory
(glutamatergic) postsynaptic currents (mEPSCs), which, however,
may have been caused by incipient neurodegeneration at P13–P15,
the time window of our experiments (Stobrawa et al, 2001). By
contrast, Nelson and co-workers more recently reported markedly
reduced frequencies and amplitudes of mIPSCs in Clcn3/ mice
(Riazanski et al, 2011) and Fahlke’s group stated that Clcn3 disrup-
tion increased frequencies and amplitudes of mEPSCs in primary
neuronal cultures (Guzman et al, 2014). We re-investigated mIPSCs
and mEPSCs in CA1 hippocampal pyramidal neurons at P14–16,
now including also Clcn3unc and Clcn4 alleles (Fig 6A–G). Again no
differences in mIPSCs between Clcn3/ and Clcn3+/+ mice were
found (Fig 6A and B). We neither observed differences in mIPSCs
between Clcn3unc/unc and Clcn3+/+ mice (Fig 6C), nor between
Clcn4+/+ and Clcn4/ mice (Fig 6D). Compared to Clcn4/ mice,
the mIPSC interevent intervals, but not amplitudes, appeared longer
in Clcn3unc/unc/Clcn4/ mice (Fig 6E). However, these mice have
the most severe neurodegeneration among the investigated geno-
types. In these mice, there also appeared to be a marginal increase in
mEPSC frequency, but not amplitudes, when compared to Clcn4
mice (Fig 6F and G). Guzman et al (2014) reported that the area of
SVs was increased by ~ 30% in Clcn3/ versus WT mice. However,
we did not observe significant changes either in the number nor the
size of SVs and endosome-like vacuoles of glutamatergic spine
synapses in Clcn3/ compared to WT brain sections (Fig EV5).
We further investigated whether ClC-3 is exocytosed together
with SV markers upon electrical stimulation of primary hippocam-
pal neurons. These neurons were transfected with a construct in
which the genetically encoded pH-sensitive indicator pHluorin
(Miesenbo¨ck et al, 1998) was fused to a luminal loop of ClC-3 (ClC-
3-pHluorin). The fluorescence of the fusion protein is expected to
increase upon exocytosis from an acidic SV because it then faces the
more alkaline extracellular medium. Subsequent endocytosis and
vesicular acidification again reduce fluorescence. pH-sensitive
synaptobrevin 2-mOrange reported SV exocytosis. In contrast, co-
transfected ClC-3-pHluorin fluorescence did not increase in response
to action potential firing (Fig 6H), suggesting that exocytosis-compe-
tent SVs express only low amounts of ClC-3.
Discussion
The biological importance of particular ion transport processes is
most impressively demonstrated by phenotypes resulting from their
genetic manipulation in animal models, as reported here for ClC-3
and ClC-4. Our work demonstrates that the exchange of Cl for H+,
rather than the provision of a conductance, is crucial for the biologi-
cal role of ClC-3. This role became only apparent in the absence of
ClC-4 because the exchange activity of ClC-4 (Picollo & Pusch, 2005;
Scheel et al, 2005) compensated for the loss of ClC-3 Cl/H+-
exchange in Clcn3unc/unc mice in which ClC-3 mediates a Cl
conductance. In vivo, the stability of ClC-4 depends on ClC-3 with
which it forms heterodimers. The bulk of ClC-3 resides on endo-
somes and to a minor degree also on SVs. However, we could not
confirm reports suggesting an important role of ClC-3 in synaptic
physiology (Riazanski et al, 2011; Guzman et al, 2014).
Heteromeric CLCs
CLC Cl channels and transporters (Jentsch, 2008; Jentsch & Pusch,
2018) function as dimers with one permeation pathway per CLC
monomer (Ludewig et al, 1996; Middleton et al, 1996; Weinreich &
Jentsch, 2001; Dutzler et al, 2002). In addition to homodimers,
some CLC proteins can form heterodimers (Lorenz et al, 1996;
Mohammad-Panah et al, 2003; Suzuki et al, 2006; Guzman et al,
2017) which may display novel properties (Lorenz et al, 1996). It
has remained unclear whether CLC heterodimers exist in vivo and
whether they are biologically important. We found that in vivo a
substantial portion of ClC-4 is found in physical association with
ClC-3. Whereas ClC-3 reaches endosomes without ClC-4, the pres-
ence of ClC-4 in endosomes largely depends on ClC-3. In the
absence of the ClC-3 binding partner, a large fraction of ClC-4
remains in the ER where it is probably degraded. As indicated by
the even more severe pathology of Clcn3//Clcn4/ compared to
Clcn3/ mice, the reduced ClC-4 levels in Clcn3/ mice likely
contribute to their neurodegeneration (Stobrawa et al, 2001; Yoshi-
kawa et al, 2002). The reason for the ER retention of ClC-4 remains
unclear. Several membrane proteins display arginine-based reten-
tion motifs that are shielded by interaction partners to facilitate ER
exit (Zerangue et al, 1999; Michelsen et al, 2005). However, no
functional arginine-based or other linear signal sequence could be
identified in the N-terminus of ClC-4 that reportedly localizes it to
the ER (Okkenhaug et al, 2006).
Although both ClC-3 and ClC-4 are widely expressed across
tissues, their relative expression levels vary (Fig EV2B). Expression
databases (https://gtexportal.org/) suggest that both isoforms are
expressed to roughly similar levels in brain and muscle, but that the
ClC-3/ClC-4 mRNA ratio is markedly higher in most other tissues.
Cells probably co-express heteromeric and homomeric ClC-3 and
ClC-4 exchangers since ClC-3 does not require ClC-4 for ER exit, and
because a fraction of ClC-4 can leave the ER without ClC-3. This is
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Figure 6. Impact of Clcn3 and Clcn4 genotypes on synaptic vesicle exocytosis.
A–E Miniature inhibitory postsynaptic currents (mIPSCs) measured in CA1 pyramidal neurons in different mouse models at P14–P16. (A) Example mIPSCs of WT (left)
and Clcn3/ neurons. (B–E) Mean values  SEM and cumulative histogram of amplitude (top) and frequency/interevent–interval (bottom) of mIPSCs in different
mouse models as indicated. Several cells of three mice of each genotype were analyzed. Compared genotypes were siblings. No difference in amplitude or
frequency/interevent–interval distribution of mIPSCs was found in (B) Clcn3/ and Clcn3+/+ (Clcn3+/+: 16 cells, Clcn3/: 15 cells; mean amplitude: P > 0.8, t-test;
mean frequency: P > 0.4, MW test), in (C) Clcn3unc/unc and Clcn3+/+ (Clcn3+/+: 21 cells, Clcn3unc/unc: 13 cells; mean amplitude: P > 0.7; mean frequency: P = 0.3, t-
test), and in (D) Clcn4/ and Clcn3+/+ (Clcn3+/+: 18 cells, Clcn4/: 18 cells; mean amplitude: P > 0.3, t-test; mean frequency: P = 0.6, MW test). (E) No difference in
mean amplitude (P > 0.5, t-test), in cumulative amplitude and mean frequency of mIPSCs (P > 0.1, t-test) was found in Clcn3unc/unc/Clcn4/ and Clcn3+/+/Clcn4/.
The interevent–interval distribution was shifted to the right, indicating a reduced frequency of mIPSCs in Clcn3unc/unc/Clcn4/ (KS test, P < 0.05; Clcn3+/+/Clcn4/:
16 cells, Clcn3unc/unc/Clcn4/: 12 cells).
F, G Miniature excitatory postsynaptic currents (mEPSCs). (F) Example traces of mEPSCs in WT and Clcn3/ neurons. (G) No significant difference between Clcn3unc/unc/
Clcn4/ and Clcn3+/+/Clcn4/ mEPSCs in mean amplitudes (P > 0.9, t-test) or in the distribution of amplitudes (Clcn4/: 12 cells, 2 mice; Clcn3unc/unc/Clcn4/:
eight cells, two mice).
H Primary hippocampal neurons co-transfected with ClC-3 and synaptobrevin (syb2), both luminally tagged with pHluorin or the pH-sensitive mOrange (Ramirez
et al, 2012), respectively, were stimulated by 200 action potentials (APs) at 20 Hz (indicated by bar). Vesicle exocytosis was monitored by fluorescence increase
upon exposure to extracellular neutral pH. Note that only Syb2 and not ClC-3 shows signs of exocytosis. Traces were corrected for photobleaching. The initial decay
of the pHluorin signal is probably due to the high light exposure, which forces the fluorophores into a transient dark state (Dean et al, 2011). Averaged fluorescence
traces (n = 10), error bars, SEM.
Source data are available online for this figure.
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indicated by the mature ClC-4 band in Western blots of Clcn3/
tissue and by robust plasma membrane currents upon ClC-4 overex-
pression (Friedrich et al, 1999; Picollo & Pusch, 2005; Scheel et al,
2005).
Transport properties of ClC-3 and ClC-3/-4 heteromers
Due to difficulties in obtaining sizeable plasma membrane currents
with ClC-3, various endogenous and mutually exclusive currents
were assigned to ClC-3 (Kawasaki et al, 1994, 1995; Duan et al,
1997; Huang et al, 2001). However, analysis of splice variants and
mutants with increased surface expression have firmly established
that ClC-3 generates strongly outwardly rectifying currents (Li et al,
2000; Picollo & Pusch, 2005; Matsuda et al, 2008; Guzman et al,
2013, 2015; Okada et al, 2014; Rohrbough et al, 2018) resembling
those of the closely related ClC-4 and ClC-5 exchangers (Steinmeyer
et al, 1995; Friedrich et al, 1999). Neutralizing the “gating gluta-
mate” linearizes the current/voltage relationship of ClC-3
(Fig EV1B) (Matsuda et al, 2008; Okada et al, 2014; Rohrbough
et al, 2018) and abolishes the coupling of Cl flux to H+-counter-
transport like in other vesicular CLCs (Friedrich et al, 1999; Picollo
& Pusch, 2005; Scheel et al, 2005; Neagoe et al, 2010; Leisle et al,
2011), as convincingly shown for a chimera in which the ClC-3
N-terminus was replaced by ClC-5 (Rohrbough et al, 2018). The
hypothesis that ClC-3 facilitates acidification of endosomes by
increasing the capacitance of their membrane (Guzman et al, 2013)
is not viable when luminal buffering of H+ is taken into account
(Jentsch & Pusch, 2018).
We do not know whether the ion transport properties of ClC-3/
ClC-4 heteromers differ in detail from a superposition of those from
the respective homodimers. Currents elicited by co-expressing ClC-3
and ClC-4 are overwhelmingly mediated by ClC-4 because ClC-3
current amplitudes are very low. The Cl/H+-exchange of ClC-4 is
almost certainly maintained in a heterodimer with the uncoupled
ClC-3unc protein because ion translocation pathways of CLC proteins
are entirely enclosed in each individual subunit (Ludewig et al,
1996; Weinreich & Jentsch, 2001; Dutzler et al, 2002). Protonation
of the side chain of the “gating glutamate”, which protrudes into the
permeation pathway, is thought to underlie gating of CLC channels
and Cl/H+-exchange of CLC exchangers like ClC-3 (Dutzler et al,
2002, 2003; Accardi & Miller, 2004). Hence not only ion selectivity
and single channel conductance (Ludewig et al, 1996; Weinreich &
Jentsch, 2001), but also other pore properties such as Cl/H+-
coupling are independent from the other subunit of the dimer, as
demonstrated with concatemers linking WT and uncoupled ClC-5
subunits (Zdebik et al, 2008). The changed properties of ClC-1/
ClC-2 (Lorenz et al, 1996) and ClC-0/ClC-1 (Weinreich & Jentsch,
2001) Cl channels or ClC-7/ClC-7mutant chloride/proton exchangers
(Ludwig et al, 2013) are caused by altered common gating that
acts on both subunits (Ludwig et al, 2013). Since ClC-3 and ClC-4
currents display similar activation kinetics, no effect of
heteromerization is expected.
ClC-3 localizes predominantly to endosomes rather than SVs
Although initially thought to be a plasma membrane Cl channel
(Kawasaki et al, 1994, 1995; Duan et al, 1997; Huang et al, 2001), it
is now established that ClC-3 is a Cl/H+-exchanger that resides
almost exclusively on intracellular membranes. Upon overexpres-
sion in COS-7 cells, only ~ 6% of the protein was found at the
plasma membrane where it was rapidly endocytosed and targeted to
endosomes (Zhao et al, 2007). We expect native plasma membrane
expression to be even much lower. In any case, ClC-3 is unlikely to
be active at the plasma membrane because its currents are only
observed at non-physiological cytoplasm-positive voltages.
Most groups now concur that ClC-3 is expressed on endosomes,
but almost all studies relied on heterologous overexpression (e.g., Li
et al, 2002; Hara-Chikuma et al, 2005b; Suzuki et al, 2006;
Weylandt et al, 2007; Zhao et al, 2007). Anti-ClC-3 antibodies were
often used without KO controls and can show significant cross-reac-
tivity (Jentsch et al, 2010). Our own anti-ClC-3 antibody has been
validated by using Clcn3/ tissue, but gives only faint signals in
IHC. To unambiguously localize ClC-3 in native tissues, we newly
generated knock-in mice expressing a Venus-ClC-3 fusion protein.
Clcn3ven/ven mice revealed that native ClC-3 is found on intracellular
punctate structures, which mainly represent early, recycling and
partially late endosomes.
Several groups, including our own (Stobrawa et al, 2001;
Maritzen et al, 2008), have suggested the presence of ClC-3 on SVs
(Salazar et al, 2004; Seong et al, 2005; Grønborg et al, 2010;
Riazanski et al, 2011; Guzman et al, 2014) or synaptic-like
microvesicles of neuroendocrine cells (Salazar et al, 2004; Maritzen
et al, 2008). However, it was later reported that only every 2,000th
SV may contain a ClC-3 molecule (Schenck et al, 2009). One
proteomic study found ClC-3 on SVs (Grønborg et al, 2010),
whereas three others did not (Takamori et al, 2006; Boyken et al,
2013; Biesemann et al, 2014), and reports concerning effects of ClC-
3 disruption on SV function are contradictory (Stobrawa et al, 2001;
Schenck et al, 2009; Riazanski et al, 2011; Guzman et al, 2014).
We therefore used multiple approaches to re-investigate a poten-
tial role of ClC-3 in SVs. Calibrated Western blots from SV-enriched
LP2 fractions suggested the presence of one ClC-3 protein per ~ 25
SVs (4%) in mouse brain, considerably higher than 1 ClC-3 per
2,000 SVs as reported by Schenck et al (2009). These authors have
overestimated VGLUT1 levels due to an inadvertent epitope shield-
ing in their antibody calibration procedure that used C-terminally
tagged VGLUT1 (S. Takamori, personal communication). Quantita-
tive single-vesicle imaging of SVs from Clcn3ven/ven mice yielded an
even higher estimate (≥ 10% ClC-3 expressing SVs), whereas electri-
cally stimulated exocytosis of SVs from ClC-3-phluorin transfected
neurons failed to provide evidence for a significant presence of ClC-
3 on SVs. Each of these techniques is fraught with potential pitfalls
such as epitope shielding with epitope-tagged proteins, or effects of
epitope addition or overexpression on the trafficking of ClC-3. With
these caveats in mind, our experiments suggest that SVs do express
ClC-3, with about 4–15% of SVs being positive. ClC-3-positive SVs
may represent a functionally distinct subpopulation of SVs, such as
endosomal intermediates in SV reformation after endocytosis.
However, we did not observe an impact of the loss of ClC-3 on
synaptic function before the onset of neurodegeneration and the
concomitant loss of VGLUT1.
ClC-3 was proposed to support SV acidification by shunting H+-
ATPase currents (Stobrawa et al, 2001). Indeed, acidification of SV
preparations from Clcn3/ mice was reduced (Fig 5C) as reported
before (Stobrawa et al, 2001; Riazanski et al, 2011). However, one
previous study (Riazanski et al, 2011) based this conclusion in part
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on a so-called “rat ClC-3 KO model” in which ClC-3-containing vesi-
cles were immuno-depleted from SV preparations. Obviously, the
ClC-3-depleted vesicle population is not equivalent to SVs from
Clcn3/ mice. Our present work supports the suggestion of Taka-
mori and colleagues (Schenck et al, 2009) that the reduced acidifi-
cation of SVs from Clcn3/ mice (Stobrawa et al, 2001) can be
attributed to a reduction of the vesicular glutamate transporter
VGLUT1 which we had observed earlier (Stobrawa et al, 2001).
VGLUT1 appears to operate in several modes which includes a Cl
conductance (Schenck et al, 2009; Preobraschenski et al, 2014;
Martineau et al, 2017). The fact that > 65% of purified SVs are gluta-
matergic (Takamori et al, 2006) is compatible with this hypothesis.
The impairment of SV acidification correlated with a reduction of
VGLUT1 levels during neurodegeneration in both Clcn3/ and
Clcn3unc/unc/Clcn4/mice. Although ClC-3 and ClC-4 are expressed
from birth on, no acidification defect was observed in Clcn3/ mice
before the onset of neurodegeneration. Since the loss of VGLUT1
roughly correlated with the degree of neurodegeneration, it might be
owed to a preferential loss of mainly glutamatergic hippocampal
neurons or, less likely, from a trafficking defect of VGLUT1.
The previously proposed role of ClC-3 in SV acidification
suggested that it might affect SV neurotransmitter uptake. Depend-
ing on the particular neurotransmitter transporter, this uptake is
driven by DpH and/or the transmembrane voltage (Dw). Glutamate
uptake depends mainly on Dw, whereas the activity of the vesicular
GABA transporter VGAT depends on both parameters (Hnasko &
Edwards, 2012). If ClC-3 provides a significant SV conductance, one
would expect that Clcn3 disruption increases Dw and hence gluta-
mate uptake. This should translate into larger miniature excitatory
postsynaptic currents (mEPSCs) that are proportional to the vesicu-
lar glutamate content. Since disruption of a SV Cl conductance
would not only increase Dw, but also decrease DpH, an effect on
GABA loading and mIPSCs is difficult to predict. In general, mPSCs
must be interpreted cautiously because degenerative changes in
Clcn3/ neurons may begin earlier than is apparent from light
microscopy and since the lack of the overwhelmingly endosomal
ClC-3 protein may affect intracellular trafficking of key proteins.
We previously measured mIPSCs and mEPSCs in CA1 pyramidal
neurons of WT and Clcn3/ mice before the onset of neuronal cell
loss (P13–P15) (Stobrawa et al, 2001). We found no differences of
mIPSC amplitudes or frequencies and only a slight increase in
mEPSCs that was apparent in the amplitude distribution, but not in
their mean values (Stobrawa et al, 2001). In contrast, Riazanski et al
(2011) more recently described significantly lower mIPSC ampli-
tudes and a ~ 40% decrease in their frequency, and Guzman and
colleagues reported a 20% increase in mean mEPSC amplitudes and
an ~ 80% increase in mEPSC frequencies in hippocampal neurons
cultured from WT and Clcn3/ mice (Guzman et al, 2014).
We re-investigated this issue and measured mIPSCs in hippocam-
pal slices from 13- to 15-day-old mice. mIPSC amplitudes or frequen-
cies were neither changed in Clcn3/, nor in Clcn3unc/unc or
Clcn4/ mice. Only Clcn3unc/unc/Clcn4/ mice, which show the
strongest neurodegeneration, displayed reduced mIPSC frequencies.
The effects reported by Riazanski et al (2011), who studied Clcn3/
mice (Dickerson et al, 2002) at P18–P25, might thus be due to incipi-
ent neurodegeneration. We examined mEPSCs in Clcn3unc/unc/
Clcn4/ mice and again found no differences in mEPSC amplitudes.
In conclusion, our data neither support a significant presence of
ClC-3 on SVs, nor a degeneration-independent role in synaptic trans-
mission. Our data do not support the influence of Clcn3 disruption
on SV size described by Guzman et al (2014) either.
Biological roles of ClC-3 and ClC-4
The strong reduction of ClC-4 in Clcn3/ mice likely contributes to
their severe neurodegeneration although Clcn4/ mice lack obvi-
ous phenotypes (Rickheit et al, 2010; Hu et al, 2016). In humans,
CLCN4 mutations were identified in patients with mental retardation
and sometimes seizures (Veeramah et al, 2013; Hu et al, 2016;
Palmer et al, 2018), but no overt neurodegeneration was reported.
Primary cultures of hippocampal neurons from Clcn4/ mice
showed borderline reductions in dendritic branching (Hu et al,
2016), but no changes in brain morphology were observed here
(Appendix Fig S2).
Our work suggests that the neurodegeneration of Clcn3/ mice is
owed to a decrease of endosomal Cl/H+ exchange below a critical
threshold which is passed because loss of ClC-3 also entails a marked
decrease of ClC-4. When endosomal Cl/H+ exchange is further
reduced (and possibly abolished, if no other CLCs are present in the
relevant compartments) as in Clcn3unc/unc/Clcn4/ or Clcn3//
Clcn4/ mice, the ensuing pathology is even more pronounced
(Fig 3A and B). Comparison of Clcn3unc/unc/Clcn4/ with Clcn3//
Clcn4/ mice suggests that the uncoupled ClC-3unc Cl conductance
might partially substitute for cellular functions of ClC-3 Cl/H+
exchange. Alternatively or additionally, a lack of ClC-3 protein interac-
tions, which will be retained with the ClC-3unc mutant, might account
for the more severe phenotype of Clcn3//Clcn4/ mice. Indeed,
we previously found partial rescues of Clcn7/ phenotypes (Kornak
et al, 2001; Kasper et al, 2005) both by the uncoupled conductance of
ClC-7unc in Clcn7unc/unc mice (Weinert et al, 2010) and by the mere
presence of the ClC-7 protein in Clcn7td/td mice that express a trans-
port-deficient mutant (Weinert et al, 2014).
As repeatedly shown for ClC-5 (Gu¨nther et al, 2003; Hara-
Chikuma et al, 2005a; Novarino et al, 2010; Gorvin et al, 2013),
endosomal/lysosomal CLCs may support vesicular acidification by
neutralizing H+-ATPase currents. Steady-state pH (Yoshikawa et al,
2002) and active acidification (Hara-Chikuma et al, 2005b) of endo-
somes from Clcn3/ hepatocytes were reported to be more alkaline
and reduced, respectively. As both ClC-3 and ClC-4 are expressed in
liver, a reduction of ClC-4 may have contributed to this effect. A
mild alkalinization (pH 6.6 vs. 6.1) was reported for transferrin-
positive compartments of Clcn3/ hepatocytes (Hara-Chikuma
et al, 2005b), but we found no significant change in the pH of these
compartments in cultured Clcn3/ neurons. Acidification of intra-
cellular compartments does not always depend on Cl. For instance,
lysosomes lacking ClC-7 display normal steady-state pH (Kasper
et al, 2005; Weinert et al, 2010, 2014) because their acidification
depends largely on cation counterflux (Steinberg et al, 2010).
Given that Cl/H+-exchange accumulates Cl in acidic vesicles
in a secondary active process, we expect that luminal Cl concentra-
tions in Clcn3/ and Clcn3unc/unc/Clcn4/endosomes are
decreased. Lower Cl concentrations have been measured in lyso-
somes of cells derived from Clcn7/ and Clcn7unc/unc mice (Wein-
ert et al, 2010, 2014) and in Caenorhabditis elegans lysosomes
lacking the ClC-7 ortholog (Chakraborty et al, 2017). Whereas lyso-
somes can be easily loaded with dextran-coupled indicators, we are
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currently unable to specifically target Cl sensors to endosomes.
ClC-3 may also influence the voltage across endosomal membranes.
Model calculations predict more negative luminal voltages with
2Cl/H+-exchangers than with Cl channels (Weinert et al, 2010),
but no reliable methods to quantitatively measure endosomal volt-
age exist. In conclusion, disruption of ClC-3 may affect the luminal
pH and Cl concentration and the transmembrane voltage of ClC-3-
expressing vesicles. However, for Clcn3unc/unc/Clcn4/ mice,
which display more severe pathology than Clcn3/ mice, no
change in luminal pH is expected because the ClC-3unc Cl conduc-
tance may support acidification as observed in ClC-5unc mice
(Novarino et al, 2010).
Our work suggests that the severe neurodegeneration observed
in Clcn3/ mice or Clcn3unc/unc/Clcn4/ mice is due to an impair-
ment of endosomal, rather than SV function. The loss of ClC-3,
together with the concomitant substantial reduction of its
heteromerization partner ClC-4, may alter intracellular trafficking as
in other neurodegenerative diseases caused by mutations in
endolysosomal ion transport proteins (LaPlante et al, 2006; Ouyang
et al, 2013). The observation that the replacement of the Cl/H+-
exchange activity of ClC-3 by a Cl conductance leads to severe
pathology when not compensated by ClC-4 generalizes the emerging
picture (Jentsch, 2007; Braun et al, 2010; Novarino et al, 2010;
Weinert et al, 2010) that the function of endosomes and lysosomes
depends on Cl accumulation or changes in membrane potential
brought about by CLC Cl/H+ exchangers.
Materials and Methods
Mice
The generation of Clcn3/ and Clcn4/ mice (Stobrawa et al,
2001) has been described. For the generation of Clcn3unc/unc mice
11.7 kb of mouse genomic sequence extending from exon 2 to 6 of
Clcn3 were amplified from R1 ES cells and cloned into pKO Scram-
bler plasmid 901 (Lexicon Genetics Incorporated) containing a dtA
cassette (diphtheria toxin A cassette). A neomycin (neo) resistance
cassette flanked by FRT sites was introduced between exon 5 and 6
to select for recombination in embryonic stem (ES) cells. Exon 5
was modified by insertion of the E224A mutation. Targeted R1 ES
cells were screened by Southern blot (SB) analysis using EcoRV and
an external 1.2-kb probe. Correctly targeted ES cells were injected
into C57Bl/6 blastocysts. Chimeric animals were crossed with FLPe
recombinase-expressing “deleter” mice (Farley et al, 2000) and
resulting heterozygous animals (Clcn3+/unc) were inbred to yield
Clcn3unc/unc. Exon 5 of the genomic Clcn3unc/unc gene was amplified
with intronic primers and sequenced. To obtain double genetically
modified Clcn3unc/unc/Clcn4/ mice, heterozygous Clcn3+/unc/
Clcn4+/ mice were inbred.
To generate Clcn3ven/ven mice, 14.3 kb of mouse genomic
sequence extending from exon 1 to 3 of Clcn3 was subcloned into
pKO Scrambler plasmid 901 (Lexicon Genetics) containing a dtA
cassette from a murine Clcn3 k clone 7 isolated from a 129SVJ
mouse genomic library cloned into pBlue. A puromycin (puro) resis-
tance cassette flanked by loxP sites was introduced between exon 1
and 2 to select for recombination in ES cells. Venus cDNA was
inserted by recombinant PCR onto the start ATG of the Clcn3 ORF
which codes for the transcript variant a (NM_007711.3). Addition-
ally, a silent point mutation was introduced to obtain an NcoI
restriction site for subsequent SB analysis. The Venus and Clcn3
sequences were separated by a 12-bp linker. Correctly targeted ES
cells were injected into C57Bl/6 blastocysts. Chimeric animals were
crossed with Cre-recombinase-expressing “deleter” mice (Schwenk
et al, 1995), and resulting heterozygous animals (Clcn3+/ven) were
inbred to yield Clcn3ven/ven. All experiments were performed with
mice in a mixed C57Bl/6-129/Svj genetic background, always using
littermates as controls. Animals were housed under standard condi-
tions in the animal facility of the MDC according to institutional
guidelines and kept on a 12-h light/dark cycle. LAGeSo, Berlin,
Germany, approved all experimental procedures.
Antibodies
Primary antibodies were as follows: anti-ClC-3 and rabbit anti-ClC-4
(Maritzen et al, 2008), rabbit anti-ClC-5 (Gu¨nther et al, 1998),
rabbit anti-synaptophysin (#101 002, Synaptic Systems), chicken
anti-GFP (#1020 Aves lab), mouse anti-GFP (#A-11120, Life Tech-
nologies), rabbit anti-GFP (#A-11122, Life Technologies), rat anti-
Lamp-1 (#553792, BD Pharmingen; clone 1D4B; BD Biosciences),
mouse anti-Lamp-1 (clone H4A3, DHSB), rabbit anti-EEA1 (#PA1-
063A, Thermo Scientific), mouse anti-EEA1 (#610457, Transduction
Laboratories), mouse anti-TfR (#13-6890, Zymed), guinea pig anti-
VGLUT1 (#135 304, Synaptic Systems), mouse anti-VGLUT1 (#135
311, Synaptic Systems), rabbit anti-VGLUT1 (#135 303, Synaptic
Systems), guinea pig anti-VGLUT2 (#135 404, Synaptic Systems),
mouse anti-VGAT (#131 011, Synaptic Systems), rabbit anti-clathrin
heavy chain (ab21679, Abcam), rabbit anti-LC3 (#AP1802a,
Abgent), rabbit anti-GluR4 (#06-308, Millipore), rabbit anti-GABAA-
receptor a1 (#06-868, Millipore), mouse anti-MAP2 (#MAB3418,
Millipore), mouse anti-PSD95 (#MA1-046/CP35, Thermo Scientific/
Calbiochem), mouse anti-GFAP (#G3893, Roche), mouse anti-APC
(#OP80, Calbiochem), mouse anti-GM130 (#610823, BD Bios-
ciences), mouse anti-rab4 (#610889, BD Biosciences), mouse anti-
rab3 (#107 011, Synaptic Systems), mouse anti-adaptin Ƴ (AP-1,
#610385, BD Transduction) mouse anti-PDI (#SPA-891, StressGen),
mouse anti-cathepsin D (#28-0002, Zymed), rabbit anti-b-actin
(#A2066, Sigma-Aldrich), rabbit anti-a-tubulin (#ab15246, Abcam),
rat anti-HA (3F10, #118676423001, Roche). Secondary antibodies
were coupled to Alexa Fluor 488, 546, 633 (Invitrogen) or HRP
(Jackson ImmunoResearch).
Biochemical methods
For membrane preparation, tissues were homogenized in PBS with
protease inhibitors (Complete, Roche) and cleared two times by
centrifugation at 1,000 g for 10 min. Membranes were pelleted at
270,000 g for 30 min and subsequently resuspended in PBS supple-
mented with protease inhibitors and 2% (w/v) SDS. For whole
tissue homogenates, organs were homogenized in PBS with 1% (v/
v) NP-40 and protease inhibitors (Complete, Roche) and incubated
for 30 min on ice. After centrifugation for 10 min at 20,800 g, the
supernatant was used for SDS–PAGE. Equal amounts of protein
were separated by SDS–PAGE and blotted onto nitrocellulose.
For deglycosylation, 60 lg of lysate was denatured at 65°C
for 5 min in 0.5% (w/v) SDS for PNGase F (Roche) or in 0.5%
ª 2020 The Authors The EMBO Journal 39: e103358 | 2020 13 of 19
Stefanie Weinert et al The EMBO Journal
SDS, 40 mM DTT and 50 mM Na-acetate pH 5.2 for EndoH
(Roche) treatment. After adjusting to 1% (v/v) NP-40 and
1.3 mM EDTA, 1 unit of PNGase F and 0.015 units of EndoH
were added and samples incubated at 37°C for 2 h. For
immunoprecipitation experiments, ClC-3 and ClC-4 antibodies
were bound to protein A sepharose (GE Healthcare). Brain
membranes were pelleted and solubilized in homogenization
buffer (150 mM NaCl, 25 mM MES pH 6.5) containing 1%
Triton X-100. Non-solubilized material was removed by a
20,360 g spin. After incubation with the protein A sepharose–
antibody complexes for 12 h at 4°C and washing, samples were
eluted in 2× SDS sample buffer at 75°C.
Quantification of ClC-3/VGLUT1 ratio in LP2 fraction
To estimate ClC-3 copy number relative to VGLUT1, we tran-
siently expressed mVGLUT1 and hClC-3 in HEK cells, both of
which were N-terminally tagged with EGFP. The cells were lysed
in equal volumes of 1× PBS containing 1% Triton X-100 and
protease inhibitors (Complete, Roche), and soluble supernatant
was used as standard for calibrating VGLUT1 and ClC-3
antibodies. Probing with GFP allowed us to directly compare the
relative amounts of VGLUT1 and ClC-3 in the lysates. On average,
we found that the GFP-hClC-3 lysate contained about 4.33 × more
ClC-3 molecules than the GFP-VGLUT1 lysate contains VGLUT1
molecules. We then compared the two standards with different
amounts of LP2 fractions (see below for LP2 preparation) from
mouse brain by using our KO-controlled ClC-3 antibody and a
VGLUT1 antibody directed opposite the GFP tag against the very
C*terminus of VGLUT1 (see above). While the standard for
VGLUT1 roughly corresponds to 2.5 lg of that LP2 fraction, the
signal of the standard for ClC-3 corresponds to ~ 140 lg. There-
fore, the amount of VGLUT1 and ClC-3 standards compared to
LP2 fraction differs by a factor of 56. Given that the standard for
ClC-3 contains 4.33 times more ClC-3-molecules than the standard
for VGLUT1, the actual copy number of ClC-3 in the LP2 fraction
is about 13 times lower.
Fluorescence resonance energy transfer (FRET) microscopy
COS-7 cells were transfected as described above. Imaging was
performed in physiological solution (in mM: 115 NaCl, 3 KCl, 1
MgSO4, 1 MgCl2, 1 CaCl2, 20 HEPES, 10 glucose, pH 7.4), using a
LSM 510 META microscope (Carl Zeiss) equipped with a 40× oil-
immersion objective (numerical aperture = 1.3), an argon laser
(k = 514 nm), and an infrared laser (k = 810 nm, two photon).
Donor (ECFP) emission spectra were recorded at 810 nm (two
photon) excitation before and after acceptor photobleaching (EYFP,
514 nm laser).
Fo¨rster resonance energy transfer efficiencies were calculated
from the donor emission at k = 436 - 500 nm before and after
photobleaching, using the following equation:
E ¼ 1 I0
Ipb
E: energy transfer efficiency; I0 = donor intensity before accep-
tor photobleaching; Ipb = donor intensity after acceptor
photobleaching.
LP2 preparations and SV fraction acidification
Crude SVs (LP2) were purified as described (Huttner et al, 1983;
Takamori et al, 2000). LP2 were resuspended in homogenization
buffer [320 mM sucrose, 4 mM HEPES-KOH (pH 7.4)]. Acidification
was measured with 100 lg LP2 by acridine orange quenching in
0.8 ml of assay buffer (115 mM sucrose, 60 mM KCl, 4 mM K2SO4,
200 lM acridine orange, 1.2 mM K-ATP, 10 mM MOPS, pH 7.3) in
a Safas fluorometer (excitation, 492 nm, emission, 520 nm) at 32°C.
The addition of 5 mM MgCl2 after 60 s started the reaction. FCCP
(10 lM) addition after 4 min dissipated the H+-gradient and termi-
nated the reaction. Traces were normalized to the fluorescence at
t = 60 s.
Single-vesicle imaging of venus-tagged SVs
Synaptic vesicles were purified from the brain of adult
Clcn3ven/ven mice and immobilized on poly-L-lysine coated glass
cover slips as previously described (Farsi et al, 2016). To perform
IF imaging, primary labeled antibodies against VGLUT1 (Oyster-
650 labeled, Cat. #135 303C5, Synaptic Systems) or synaptophysin
(Oyster-650 labeled, Cat. #101 011C5, Synaptic Systems) were
used. Prior to IF, immobilized SVs were fixed using 4%
paraformaldehyde and blocked by 30-min incubation with phos-
phate-buffered saline (PBS) containing 5% bovine serum albumin
(BSA). Imaging of SVs was performed using a Nikon Eclipse Ti-
inverted microscope equipped with iLAS2 TIRF (Visitron Systems)
and an EM-CCD camera (iXon+ DU-897E-BV; Andor Technology).
Excitation was performed at 488 nm (for Venus imaging) and
640 nm (for IF imaging), and emission of SVs was collected
through a quadband (405/488/561/647 nm, Chroma 89902) emis-
sion filter.
Histology and electron microscopy
Deeply anesthetized mice were perfused with 4% (w/v) PFA in
PBS, and isolated tissues were postfixed overnight at 4°C. Three-
micrometer paraffin sections of retina were used for H&E and Nissl
staining, 8-lm paraffin sections of the brain for Nissl staining, and
8-lm cryosections for IHC. For IHC, sections were postfixed with
4% (w/v) PFA, permeabilized using 0.2% (v/v) Triton X-100 in PBS
and blocked with 3% (w/v) BSA in PBS. Antibody incubation was
in blocking buffer overnight at 4°C. For some ClC-3 labeling experi-
ments, an antigen retrieval step (10 min in sodium citrate buffer,
pH 6.0, at 95°C) was included after fixation.
For DAB peroxidase staining on paraffin sections, HRP-conju-
gated secondary antibodies were used (DAKO Envision+ HRP
system). The peroxidase reaction was started using 500 mg/ml
diaminobenzidine, 10 mM imidazole, 0.3% ammonium nickel
sulfate, 0.003% H2O2 in 50 mM Tris; pH 7.6. Sections were washed
and mounted in Kaiser’s glycerol gelatine (Merck). Sections were
then examined with a Zeiss Axiophot.
For electron microscopy, mice were perfused with 4% (w/v)
PFA and 2.5% (v/v) glutaraldehyde in 0.1 M phosphate buffer
(pH 7.4). Brains were cut in 200-lm sections with a vibratome,
postfixed in 1% osmium tetroxide and 1.5% potassium hexa-
cyanoferrat, and embedded in epoxy resin. Layer 4–5 of
secondary visual cortex just above hippocampus was trimmed
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and ultrathin sectioned. Glutamatergic synapses were identified
by presence of their prominent postsynaptic densities and spine
heads. Images were done using Zeiss EM 900 microscope and
Morada G2 camera. Four pairs of wild-type and ClCn3/
animals were acquired with 20–25 boutons per animals analyzed
for vesicle number. Vesicle sizes were analyzed in more than
700 vesicles per genotype.
Clcn3ven/ven and wild-type mice were perfused with 4% PFA and
0.1% glutaraldehyde, postfixed overnight at 4°C. CA3 areas of hippo-
campi were dissected and formed into 1-mm³ blocks that have been
cryoprotected in 2.1 M sucrose solution overnight and frozen in liquid
propane on pins. Modified Tokuyasu sectioning was performed as
described elsewhere. Sections were blocked with 10% BSA and
stained with Invitrogen mouse anti-GFP antibodies (1:50) and
secondary 10 nm gold coupled goat-anti-mouse antibodies (1:50;
Dianova). Sections were embedded and contrasted using a mix of
polyvinyl alcohol/sodium silicotungstate/sodium orthovanadate.
Golgi-Cox staining
Animals were sacrificed by cervical dislocation; brains were
dissected, processed, and stained using FD Rapid Golgi Stain Kit
according to the manufacturer’s instructions. 100-lm sections were
cut, stained, and examined using a Zeiss Axiophot. Clcn4+/+ and
Clcn4/ 8-week-old male littermates and 24-week-old female litter-
mates were analyzed.
Expression constructs
For cell culture expression, human ClC-3 (transcript variant a,
NM_001243372.1, but N-terminally lacking 58 amino acids) was
cloned into pCIneo (Promega) and an HA epitope was inserted
between amino acids Gly406 and Ala407 of hClC-4 (Friedrich et al,
1999) (extracytosolic loop) by PCR mutagenesis. The point mutation
to generate hClC-3unc (E224A) was introduced by PCR with primers
carrying the mutation. For whole-cell patch-clamp studies, human
ClC-3 (see above) was cloned into pEGFP-C1 (Clontech) with the
linker sequence SGLRSRE. The point mutations 4xLA (in which all
four leucines of the N-terminal dileucine cluster were mutated to
alanine) were introduced by PCR with primers carrying the mutations.
All constructs were confirmed by sequencing the complete ORF.
For pHluorin experiments in hippocampal neurons, pHluorin
was inserted by recombinant PCR into pCIneo-hClC-3 between
membrane helices L and M with linker sequences GA and TG N-
and C-terminally, respectively.
For FRET experiments, human ClC-3 and ClC-4 (see above) were
cloned into pECFP-C1 and pEYFP-C1 (Clontech). The linker
sequences were SGLRSREL and SGLRSRAQASNSVET for ClC-3 and
ClC-4, respectively.
For antibody calibration, VGLUT1 (NP_892038.2) was amplified
from mouse cDNA and cloned into pEGFP-C3 (Clontech). All
constructs mentioned above were confirmed by sequencing the
complete ORF.
Expression in cell culture and fluorescence microscopy
Plasmid DNA was transfected into cells using the PEI method (Bris-
sault et al, 2003) or FuGENE6 (Roche Applied Science) according to
the manufacturer’s instruction. Cells were grown for further 24–
48 h before fixation with 4% paraformaldehyde in PBS for 10 min.
For immunostaining, cells were incubated with 30 mM glycine in
PBS for 5 min and permeabilized with 0.1% saponin in PBS for
10 min. Both primary and AlexaFluor-coupled secondary (Molecular
Probes) antibodies were applied in PBS, 0.05% saponin supple-
mented with 3% BSA. Images were acquired with an LSM510 laser
scanning confocal microscope equipped with a 63× 1.4 NA oil-
immersion lens (Zeiss).
Primary cell culture and transfection
Hippocampi were dissected from P0 to P2 mice, dissociated with
papain (20 units/ml) at 37°C for 30 min, and triturated by pipetting.
Hippocampal neurons were placed on life cell dishes or six-well
chamber slides coated with poly-D-lysine at a cell density of
1 × 105 cells/dish. For neuronal cycling experiments, neurons were
transfected at 9–10 days in vitro (DIV) with the respective plasmid
DNA using the Calcium Phosphate Transfection Kit (Promega Inc.).
Primary cortical astrocyte cultures were prepared from P0 to P2
mouse pups of mixed sex. After dissection and removal of meninges
and blood vessels, cortices were sliced and incubated with trypsin–
EDTA (0.05%) for 30–40 min at 37°C. Tissue was triturated and
suspended in DMEM (PAN Biotech) supplemented with 10% fetal
bovine serum (Invitrogen) and 1× penicillin/streptomycin (Invitro-
gen). Cells were plated at a density of 1 × 107 cells in a 75-cm2 flask
and maintained in a 5% CO2 incubator at 37°C. The growth medium
was exchanged with fresh medium twice a week. At 7DIV or when
cells becoming ~ 90% confluent, cell culture container was vortexed
at full speed just prior to cell dissociation for further propagation of
astrocytes without contaminating oligodendrocytes.
Immunofluorescence of primary neurons and glial cells
On DIV14–18, primary neurons or glial cells were fixed with 4%
PFA/PBS for 10 min at room temperature. Fixed cells were washed,
incubated with 30 mM glycine in PBS for 5 min, and permeabilized
with 0.1% saponin in PBS for 10 min. Both primary and AlexaFlu-
or-coupled secondary (Molecular Probes) antibodies were applied in
PBS, 0.05% saponin supplemented with 3% BSA. Cells were
washed again and mounted in ImmunMount (Thermo Scientific).
Electrically stimulated SV exo- and endocytosis by
pHluorin imaging
Live imaging of primary hippocampal neurons was performed
using a sCMOS camera (Neo, Andor) on an inverted microscope
(Eclipse Ti, Nikon) with a 40× oil-immersion objective and a 200-
Watt mercury lamp (Lumen 200, Prior) under the control of
lManager (Edelstein et al, 2010). Images were acquired every 2 s
with 300 ms excitation using a filter set for pHluorin or mOrange
(F36-526/F26-518, AHF Analysentechnik). Measurements were
conducted at room temperature in physiological buffer [in mM: 170
NaCl, 3.5 KCl, 0.4 KH2PO4, 20 TES (2-[(2-hydroxy-1,1 bis(hydroxyl-
methyl)ethyl)amino]ethanesulfonic acid), 5 NaHCO3, 5 glucose, 1.2
Na2SO4, 1.2 MgCl2, 1.3 CaCl2 (pH 7.4). Osmolarity was adjusted
with mannitol to the osmolarity of the growth medium. Ten micro-
molar CNQX (6-cyano-7-nitroquinoxaline-2,3-dione, Sigma-Aldrich)
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and 50 lM APV (2-amino-5-phosphonovalerianacid, Sigma-Aldrich)
were added as specific AMPA and NMDA receptor antagonists,
respectively. Neurons were stimulated by electric field stimulation
with 200 action potentials (at 20 Hz, 100 mA) in a stimulation
chamber (RC-47FSLP, Warner Instruments), and stimulation-
induced pHluorin and mOrange responses were recorded. Only
boutons showing mOrange responses upon electrical stimulation
and pHluorin unquenching upon addition of basic buffer (physio-
logical buffer with 50 mM NaCl replaced by NH4Cl) were used for
analysis.
Unquenching of mOrange causes a much weaker fluorescence
increase than unquenching of pHluorin (mOrange2: 3.5-fold, super-
ecliptic pHluorin: 50-fold) (Lin & Schnitzer, 2016). We intentionally
fused the stronger pH sensor to ClC-3, in order to be able to see also
weak signs of exocytosis. We used strong illumination schemes and
therefore had to correct for photobleaching by fitting a monoexpo-
nential decay function (equation 1) to the signal. Bleach rates were
calculated from the lifetime of mOrange decay (equation 2). Bleach
rates were used to correct for bleaching of synaptic mOrange inten-
sity traces (equation 3).
Exponential Decay : I(t) ¼ bgþ a  et=s (1)
I(t): intensity at time t; bg : background signal; a: intensity at time
0; s : lifetime.
Bleach rate : k ¼ e1=s (2)
k: bleach rate; s : lifetime.
BleachCorrection : IbcðtÞ ¼ I (t)þ Rti¼0ð1 kÞ  ðI(i) bgÞ (3)
Ibc(t): bleach corrected intensity at time t; I(t): intensity at time t;
k: bleach rate; bg: background.
Measurement of endosomal pH
Endosomal pH was measured by ratiometric fluorescence imaging
of the pH-sensitive fluorescein-conjugated transferrin and the pH-
stable Alexa546-conjugated transferrin. Primary hippocampal
neurons were plated onto live cell dishes. When older than DIV14,
they were incubated with 200 lg/ml FITC-Tfn and 100 lg/ml Alexa-
546-Tfn at 37°C for 20 min in growth medium. FITC-Tfn acts as a pH
sensor, whereas the Alexa546-Tfn acts as an internal standard for
uptake. Cells were washed twice with imaging solution (in mM: 140
NaCl, 2.5 KCl, 1.8 CaCl2, 1 MgCl2, 20 HEPES) supplemented with 1%
BSA and 20 mM glucose) and imaged using a Zeiss LSM510 confocal
laser scanning microscope under 40 × 1.4 NA oil-immersion lens.
Using ImageJ regions of interest (ROI) were defined as areas above a
fixed fluorescence threshold. Endosomal pH was calculated from the
ratio of fluorescence intensity (Alexa546/FITC). At the end of each
experiment, in situ calibration curves were obtained in isotonic K+-
based solution (125 mM KCl, 25 mM NaCl, 20 mM HEPES for pH 7.4,
5.4, and MES for pH 4.4) supplemented with 10 lM of both nigericin
and monensin (both Sigma-Aldrich). Cells were equilibrated for at least
2 min for each pH value. The resulting fluorescence intensity ratio as a
function of pH was fit to a sigmoid and used to interpolate pH values
from the experimental ratio data.
Hippocampal slice recordings
Horizontal hippocampal slices (300 lm) were prepared from juvenile
mice (P14–P16) using standard methods. Recordings of CA1 pyrami-
dal neurons were conducted at 34°C. Extracellular solution was artifi-
cial cerebrospinal fluid (ACSF) containing (in mM): NaCl 131,
NaHCO3 29, glucose 11, KCl 2.8, CaCl2 2.5, MgSO4 1.3, NaH2PO4 1.1,
osmolarity 320 mosml/l, saturated with 95% O2/5% CO2 (pH 7.4).
Patch pipettes (2.5–4 MΩ) were filled with (in mM): CsCl 130, HEPES
10, MgATP 2, MgCl2 2, EGTA 0.2, osmolarity 280–290 mosml/l, pH
7.3. Cells were held at 70 mV and miniature IPSCs were isolated by
bath application of 1 lM TTX, 10 lM NBQX, and 50 lM D-AP5.
Miniature EPSCs were isolated by 20 lM bicuculline and 1 lM TTX.
The low frequency of spontaneous mEPSCs ( 1/min) was increased
by adding 200 mM sucrose to the bath. The currents were recorded
after an equilibration time of 2 min, low-pass-filtered at 2 kHz,
sampled at 8 kHz, and visualized by pClamp 10.2 (Molecular Devices,
Sunnyvale). Recordings were only used as long as regularly applied
voltage pulses revealed stable series resistance. pClamp 10.2 and Mini
Analysis Program (Synaptosoft, Decatur) were used for data analyses.
Patch-clamp measurements of transfected cells
Whole-cell patch-clamp experiments on HeLa cells used patch
pipettes of 3–5 MΩ resistance filled with (in mM) 110 CsCl, 10
NaCl, 0.5 CaCl2, 1 EGTA, 2 MgATP, 40 HEPES, pH 7.4. The
bath solution contained (in mM) 130 NaCl, 5 KCl, 1 MgCl2, 1
CaCl2, 10 glucose, 20 HEPES, pH 7.4. Osmolarity was adjusted
with sucrose to 280–290 mOsmol/l for the pipette solution and
to 300–310 mOsmol/l for the extracellular solution. Cells were
held at 30 mV upon reaching the whole-cell configuration and
currents were elicited using 1-s pulses ranging from 80 mV to
+140 mV. Data were acquired with an EPC-10 double amplifier
using Pulse software (HEKA).
Data analysis
Values are presented as mean  SEM (standard error of the
mean). Statistical difference between means was assessed by
the two-tailed t-test for two groups using the GraphPad Prism
software. Specific details are given in the respective figure
legends. To evaluate the statistical difference of the miniature
inhibitory postsynaptic currents, mean amplitudes and frequen-
cies were first assessed for the presence of a normal distribu-
tion using the Shapiro–Wilk test followed by the two-tailed t-
test for two groups. If the values were not normally distributed,
the Mann–Whitney test was applied. The statistical difference
between the cumulative amplitudes and cumulative interevent
intervals was assessed by the Kolmogorov–Smirnov test. Statisti-
cally significant values are indicated by *P < 0.05, **P < 0.01,
and ***P < 0.001.
Expanded View for this article is available online.
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